Tag Archives: Publications

Weekly Roundup for MARCH 22, 2019: Recent Publications in Women’s Mental Health

The excitement over the FDA approval of brexanolone (to be marketed as Zulresso) is a good place to start this week’s roundup.  Brexanolone is a derivative of the neurosteroid allopregnanolone, and, while Zulpresso was approved specifically for the treatment of postpartum depression, there is considerable research to indicate that the modulation of neurosteroid systems may… Read More »

Weekly Roundup for NOVEMBER 30, 2018: Recent Publications in Women’s Mental Health

What’s worse? Prenatal exposure to antidepressant medications or exposure to maternal depression?  Hutchison and colleagues observe that worse executive functioning was observed in the 6-year-old children of mothers with higher levels of depressive symptoms.  Prenatal exposure to SSRIs did not have any significant impact on executive functioning. Ruta Nonacs, MD PhD   A 6-year longitudinal… Read More »

Weekly Roundup for NOVEMBER 9, 2018: Recent Publications in Women’s Mental Health

At this top of the list, we have a study which looked at prenatal exposure to a wide array of psychotropic medications and risk for autism spectrum disorders in the offspring.  They found no association between exposure to SSRIs and risk for autism. Ruta Nonacs, MD PhD Association of Autism Spectrum Disorder With Prenatal Exposure… Read More »